122 related articles for article (PubMed ID: 22096963)
1. [The past, present and future treatment for chronic hepatitis B].
Okanoue T; Minami M
Nihon Rinsho; 2011 May; 69 Suppl 4():469-74. PubMed ID: 22096963
[No Abstract] [Full Text] [Related]
2. Pharmacotherapy of hepatitis B infection: a brief review.
Quan DJ
Nephrol Nurs J; 2008; 35(5):507-10, 534. PubMed ID: 18856082
[TBL] [Abstract][Full Text] [Related]
3. Rescue therapy for lamivudine-resistant chronic hepatitis B: when and how?
Liaw YF
Hepatology; 2007 Feb; 45(2):266-8. PubMed ID: 17256763
[No Abstract] [Full Text] [Related]
4. [Protocol for the antiviral therapy of chronic hepatitis B].
;
Orv Hetil; 2008 Dec; 149(49):2341-3. PubMed ID: 19042187
[No Abstract] [Full Text] [Related]
5. [Progress and perspectives in treatment of chronic hepatitis B].
Minami M; Okanoue T
Nihon Rinsho; 2011 Apr; 69(4):737-41. PubMed ID: 21591432
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus with primary resistance to adefovir.
Chang TT; Lai CL
N Engl J Med; 2006 Jul; 355(3):322-3; author reply 323. PubMed ID: 16855278
[No Abstract] [Full Text] [Related]
7. Hepatitis B: explosion of new knowledge.
Keeffe EB
Gastroenterology; 2007 Nov; 133(5):1718-21. PubMed ID: 17983813
[No Abstract] [Full Text] [Related]
8. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Benhamou Y
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
[No Abstract] [Full Text] [Related]
9. Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
Hadziyannis SJ
Aliment Pharmacol Ther; 2012 Jun; 35(12):1482. PubMed ID: 22582839
[No Abstract] [Full Text] [Related]
10. Treatment of chronic hepatitis B in HIV-infected patients in 2007.
Garcia-Gasco P; Sheldon J; Soriano V
J HIV Ther; 2007 Mar; 12(1):19-23. PubMed ID: 17589392
[No Abstract] [Full Text] [Related]
11. [Recent therapies for hepatitis B (discussion)].
Tanaka E; Suzuki F; Tanaka Y; Shiryu H
Nihon Shokakibyo Gakkai Zasshi; 2007 Oct; 104(10):1465-79. PubMed ID: 17917394
[No Abstract] [Full Text] [Related]
12. Partial virological response to nucleos(t)ide analogues in naïve patients with chronic hepatitis B: From guidelines to field practice.
Lampertico P
J Hepatol; 2009 Apr; 50(4):644-7. PubMed ID: 19231017
[No Abstract] [Full Text] [Related]
13. Antiviral treatment of chronic hepatitis B virus infections: the past, the present and the future.
Férir G; Kaptein S; Neyts J; De Clercq E
Rev Med Virol; 2008; 18(1):19-34. PubMed ID: 17966115
[TBL] [Abstract][Full Text] [Related]
14. The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection.
Buster EH; Baak BC; Bakker CM; Beuers UH; Brouwer JT; Drenth JP; van Erpecum KJ; van Hoek B; Honkoop P; Kerbert-Dreteler MJ; Koek GH; van Nieuwkerk KM; van Soest H; van der Spek BW; Tan AC; Vrolijk JM; Janssen HL
Neth J Med; 2012 Oct; 70(8):381-5. PubMed ID: 23065990
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for the treatment of chronic hepatitis B infection in children.
Shah U; Memon I; Cheema HA; Ali S; Thobani S; Mirza R
J Pak Med Assoc; 2007 Apr; 57(4):204-7. PubMed ID: 17489531
[No Abstract] [Full Text] [Related]
16. Antiviral effect of entecavir in chronic hepatitis B: influence of prior exposure to nucleos(t)ide analogues.
Reijnders JG; Deterding K; Petersen J; Zoulim F; Santantonio T; Buti M; van Bömmel F; Hansen BE; Wedemeyer H; Janssen HL;
J Hepatol; 2010 Apr; 52(4):493-500. PubMed ID: 20185191
[TBL] [Abstract][Full Text] [Related]
17. Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.
Liang Y; Jiang J; Su M; Liu Z; Guo W; Huang X; Xie R; Ge S; Hu J; Jiang Z; Zhu M; Wong VW; Chan HL
Aliment Pharmacol Ther; 2011 Aug; 34(3):344-52. PubMed ID: 21671967
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of adefovir treatment in the lamivudine-resistant chronic hepatitis B patients].
Chen CY; Tu XL; Cheng QH; Dai Y
Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):942-3. PubMed ID: 21205485
[No Abstract] [Full Text] [Related]
19. Letter: First-line monotherapies for chronic hepatitis B - indirect comparison between entecavir and tenofovir.
Maratea D; Fadda V; Trippoli S; Messori A
Aliment Pharmacol Ther; 2013 Mar; 37(5):584-5. PubMed ID: 23369168
[No Abstract] [Full Text] [Related]
20. [Improvement of health-related quality of life in chronic hepatitis B patients treated with entecavir or adefovir].
Yu JH; Li Q; Yang X; Fan WB; Xie SS; Li WW; Liu L; Chen SJ
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):305-6. PubMed ID: 21805739
[No Abstract] [Full Text] [Related]
[Next] [New Search]
